Диссертация (1174363), страница 26
Текст из файла (страница 26)
Щербаков, А. И. Парфенов, А. А. Ильченко, В.Н. Дроздов, Ю.В. Васильев,О.В. Васнев// Экспериментальная и клиническая гастроэнтерология. — 2009. - №3(3). - С. 150155.69.ЭУСбука: руководство по эндоскопической ультрасонографии/ Ред. А.М. Нечипай,С.Ю. Орлов, Е.Д. Федоров. - М.: Практическая медицина, 2013. – 305-309 с.70.Aabakken, L. Endoscopic retrograde cholangiopancreatography/ L.
Aabakken// Gastrointest.Endosc. – 2012. – N 76. – P. 516–520.71.Abdel Aziz, A.M. Pancreatitis after endoscopic retrograde cholangiopancreatography/ A.M.Abdel Aziz, G.A. Lehman// World J Gastroenterol. - 2007. – V 13 (19). – P. 2655–2668.72.Afghani, E. 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis/ E. Afghani, V.S. Akshintala, M.A.Khashab, J.K.
Law, S.M. Hutfless, K.J. Kim, A.M. Lennon, A.N. Kalloo, V.K. Singh// Endoscopy. –2014. - V 46 (7). – P. 573–580.11773.Azizawa,N.Stentplacementinthepancreaticductpreventsic sphincter dilation for removal of bile duct stones/ T. Aizawa, N. Ueno// Gastrointest. Endosc. –2001. – N 54. – P. 209-13.74.Akshintala, V.S.
Systematic review with network meta-analysis: pharmacological prophylaxisagainst post-ERCP pancreatitis/ V.S. Akshintala, S.M. Hutfless, E. Colantuoni, K.J. Kim, M.A.Khashab, T. Li, B.J. Elmunzer, M.A. Puhan, A. Sinha, A. Kamal, M.A. Lennon, P.I. Okolo, M.K.Palakurthy, A.N. Kalloo, V.K. Singh// Aliment. Pharmacol. Ther. – 2013. – V 38(11-12). – P. 132537.75.Anderloni, A. Role and timing of endoscopy in acute biliary pancreatitis/ A.
Anderloni, A.Repici// World J Gastroenterol. - 2015. – V 21(40). – P. 11205-8.76.Anderson, M.A. Complications of ERCP. The Standards of Practice Committee of theAmerican Society/ M.A. Anderson, L. Fisher, R. Jain, J.A. Evans, V. Appalaneni, T. Ben-Menachem,B.D. Cash, G.A.Decker, D.S. Early, R.D. Fanelli, D.A. Fisher, N. Fukami, J.H. Hwang, S.O.Ikenberry, T.L.
Jue, K.M. Khan, M.L. Krinsky,P.M. Malpas, J.T. Maple,R.N. Sharaf, A.KShergill, J.A. Dominitz// Gastrointest. Endosc. – 2012. - V 75(3). – P. 467–473.77.Andriulli, A. High dose of octreotide as a prophylaxis of post-ERCP pancreatitis/ A. Andriulli//Gastrointest Endosc.
– 2007. – V 66(2). – P. 421.Andriulli, A. Incidence rates of post-ERCP complications: a systematic survey of prospective studies/A. Andriulli, S. Loperfido, G. Napolitano, G. Niro, M.R. Valvano, F. Spirito, A. Pilotto,R. Forlano//Am. J. Gastroenterol. – 2007. – V 102(8). – P. 1781-8.78.Andriulli, A. Gabexate or somatostatin administration before ERCP in patients at high risk forpost-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial/ A.
Andriulli, R.Clemente, L. Solmi, V. Terruzzi, R. Suriani, A. Sigillito, G. Leandro, P. Leo, G. De Maio, F.Perri// Gastrointest Endosc. – 2002. – V 56 (4). - P. 488-495.79.Andriulli, A. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscop-ic retrograde cholangiopancreatography: a systematic analysis of benefits and associatedrisks/ A.Andriulli, R.
Forlano, G. Napolitano, P. Conoscitore, N. Caruso, A. Pilotto, P.L. Di Sebastiano, G.Leandro// Digestion. – 2007. – V 75 (2-3). – P. 156–163.80.Andriulli, A. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis/ A. Andriulli, G. Leandro, G. Niro// Gastrointest. Endosc. – 2000. – V 51 (1). – P.
1–7.81.Andriulli, A. Prophylactic administration of somatostatin or gabexate does not preventpancreatitis after ERCP: an updated meta-analysis/ A. Andriulli, G. Leandro, T. Federici, A.Ippolito, R. Forlano, A. Iacobellis, V. Annese// Gastrointest. Endosc. – 2007. – V 65 (4). – P. 624-632.11882.Andriulli, A. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial ofsomatostatin and gabexate mesylate/ A. Andriulli, L.
Solmi, S. Loperfido, P. Leo, V. Festa, A.Belmonte, F. Spirito, M. Silla, G. Forte, V. Terruzzi//Clin Gastroenterol Hepatol. – 2004. – N 2. – P.713-718.83.Arata, S. Post-ERCP pancreatitis/ S. Arata, T. Takada, K. Hirata, M. Yoshida, T. Mayumi, M.Hirota, M. Yokoe, M. Hirota, S. Kiriyama, M. Sekimoto, H. Amano, K. Wada, Y.
Kimura, T.Gabata, K. Takeda, K. Kataoka, T. Ito, M. Tanaka// J. Hepatobiliary Pancreat. Sci. – 2010. - V 17(1).– P. 70-8.84.Arcidiacono, R. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis ofacute pancreatitis after endoscopic sphincterotomy/R. Arcidiacono, P. Gambitta, A. Rossi, C.Grosso, M. Bini, G. Zanasi// Endoscopy.
– 1994. - V 26 (9). – P. 715 – 718.85.Ayub, K.Endoscopicretrograde cholangiopancreatography in gallstoneassociated acutepancreatitis/ K. Ayub, R. Imada, J. Slavin// Cochrane Database Syst. Rev. – 2004. – N 4.86.Bai, Y. Prophylactic octreotide administration does not prevent post-endoscopic retrogradecholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials/ Y. Bai, J.Gao, D.W. Zou, Z.S. Li // Pancreas. – 2008. – V 37(3).
- P. 241-6.87.Bai, Y. Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenterrandomized controlled trial/ Y. Bai, X. Ren, X.F. Zhang, N.H. Lv, X.G. Guo, X.J. Wan, Z.G. Nie, S.T.Han, P. Bie, A. Tian, M11. Ji, Z.S. Li//Endoscopy. – 2015. - V 47(5). – P. 41588.Bailey, A.A. Needle-knife sphincterotomy: factors predicting its use and the relationship withpost-ERCP pancreatitis (with video)/ A.A. Bailey, M.J. Bourke, A.J. Kaffes, K. Byth, E.Y. Lee, S.J.Williams// Gastrointest. Endosc. – 2010.
– N 71. – P. 266 – 271.89.Bang, U.C. Meta-analysis: Nitroglycerin for prevention of post-ERCP pancreatitis/ U.C.Bang, C. Nojgaard, P.K. Andersen, P. Matzen// Aliment. Pharmacol. Ther. - 2009. - V 29(10). – P.1078-85.90.Banks, P.A. Acute Pancreatitis Classification Working Group. Classification of acutepancreatitis—2012: revision of the Atlanta classification and definitions by international consensus/P.A.
Peter, T.L. Bollen, C. Dervenis, H.G. Gooszen, C.D. Johnson, M.G. Sarr, G.G. Tsiotos, S.S.Vege// Gut. – 2013. – V 62 (1). – P. 102–111.91.Baron, T.H. Rectal indomethacin to prevent post-ERCP pancreatitis/ T.H. Baron, B.K. AbuDayyeh, A.R. Zinsmeister// N. Engl. J. Med.
- 2012. – V 367 (3). – P. 277-279.92.Bello,B.MinimallyinvasivetreatmentofpancreaticB. Bello, J. B. Matthews// World J. Gastroenterol. - 2012. – V 18(46). – P. 6829-6835.necrosis/11993.Bergman, J.J.G.H.M. Is endoscopic balloon dilation for removal of bile duct stones associatedwith an increased risk for pancreatitis or a higher rate of hyperamylasemia?/ J.J.G.H.M. Bergman, A.M. Van Berkel, M.J. Bruno, P. Fockens, E.A.J. Rauws, J.G.P.
Tijssen, G.N.J. Tytgat, K. Huibregtse//Endoscopy. - 2001. – V 33(5). - P.416-420.94.Besselink, M.G. Beneficial effects of ERCP and papillotomy in predicted severe biliary pa n-creatitis /M. G. Besselink, L. P. Van Minnen, K.J. Van Erpecum, K. Bosscha, H.G. Gooszen// Hepatogastroenterology. – 2005. – V. 52(61). – P. 37–39.95.Bhatia, V. A randomized controlled trial of valdecoxib and glyceryl trinitrate for theprevention of post-ERCP pancreatitis/V.Bhatia, V.Ahuja, S.K. Acharya,P.K. Garg//J. Clin.
Gastroenterol. – 2011. – V 45(2). – P. 170-6.96.Bierig, S. M. Accuracy and cost comparison of ultrasound versus alternative imagingmodalities, including CT, MR, PET, and angiography/ S. M. Bierig, A. Jones// JDMS. – 2009. – V25(3). – P. 138–44.97.Bradley, E.L. 3rd. clinically based classification system for acute pancreatitis. Summary of theInternational Symposium on Acute Pancreatitis, Atlanta, 1992, (Review)/ E.L. Bradley// Arch Surg.
–1993. - V 128(5). – P. 586-90.98.Cennamo, V. Can a wire- guided cannulation technique increase bile duct cannulation rate andprevent post- ERCP pancreatitis?: A meta-analysis of randomized controlled trials/ V. Cennamo, L.Fuccio, R.M. Zagari, L.H. Eusebi, L. Ceroni, L. Laterza, C. Fabbri, F. Bazzoli// Am. J. Gastroenterol. 2009. - N 104. – P.
2343–2350.99.Cennamo, V. Can early precut implementation reduce endoscopic retrograde cholangiopancrea-tography-related complication risk? Meta-analysis of randomized controlled trials/ V. Cennamo, L.Fuccio, R.M. Zagari, L.H. Eusebi, L. Ceroni, L. Laterza, C. Fabbri, F. Bazzoli// Endoscopy. – 2010. –V 42 (5). – P. 381–388.100.Cennamo, V. Timing of precut procedure does not influence success rate and complications ofERCP procedure: a prospective randomized comparative study/ V. Cennamo, L. Fuccio, Repici A, C.Fabbri, D. Grilli, M.
Conio, N. D'Imperio, F. Bazzoli// Gastrointest Endosc. – 2009. – V69 (3, Pt.1). –P. 473-9.101.Cha, S.W. Does leaving a main pancreatic duct stent in place reduce the incidence of precutbiliary sphincterotomy-associated pancreatitis? A randomized, prospective study/ S.W. Cha, W.D.Leung, G.A. Lehman, J.L. Watkins, L. McHenry, E.L. Fogel, S. Sherman// Gastrointest. Endosc. –2013. – V 77(2).
– P. 209-16.102.Chahal, P. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopicretrograde cholangiopancreatography pancreatitis/ P. Chahal, P.R. Tarnasky, B.T. Petersen, M.D. To-120pazian, M.J. Levy, C.J. Gostout, T.H.Baron// Clin. Gastroenterol. Hepatol.
– 2009. – N 7. – P. 834839.103.Chan, H.H. Effect of somatostatin in the prevention of pancreatic complications after endo-scopic retrograde cholangiopancreatography/ H.H. Chan, K.H. Lai, C.K. Lin, W.L. Tsai, G.H. Lo, P.I.Hsu, M.C. Wei, E.M. Wang// J. Chin.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
